Rezension:

I'm doing a masters in law 12yo "I don't think this will drive a biotech buying frenzy,"said Morningstar analyst Karen Andersen. She noted that whoeverends up acquiring Onyx might also have been the logical buyer ofa company like BioMarin, which develops high-priced drugs usedto treat rare genetic diseases.

Bewertung: